Company intelligence / Profile preview
Daiichi Sankyo Company
Chuo-ku, Tokyo, Japandaiichisankyo.com ↗
- Ownership
- Private
- Employees
- ~15500
- Development stage
- Commercial
01
Overview
Daiichi Sankyo is a leading global pharmaceutical company with significant commercial success in cardiovascular and oncology drugs, particularly pioneering in antibody-drug conjugates such as ENHERTU (trastuzumab deruxtecan). The company’s robust pipeline includes multiple late-stage and marketed ADCs, new mRNA vaccines, and ongoing expansion of indications for major drugs. Clinical data for ENHERTU and other ADCs have demonstrated improved outcomes (e.g., progression-free survival) in HER2-positive cancers.
- Therapeutic areas
- RheumatologyInfectious DiseasesRare DiseasesDermatologyCardiovascularOncologyNeurology
- Modalities
- Small moleculeAntibody-drug conjugateMonoclonal antibodymRNA-based drugsVaccineGene therapy
- Industry
- Pharma
02
Drug pipeline
13 assets12 more assets in the full pipeline.
03
Partnerships
AstraZeneca (global co-development and commercialization of trastuzumab deruxtecan and datopotamab deruxtecan)Merck (MSD; several DXd ADCs and MK-6070, a bispecific T-cell engager)
Beyond the preview
Go deeper on Daiichi Sankyo Company.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Daiichi Sankyo Company.